For active substances whose approval expires by 31 December 2018 at the latest, it is appropriate to allocate the evaluation for the purposes of the renewal procedures to the Member States, naming for each active substance a rapporteur and a co-rapporteur.
Toimeainete puhul, mille heakskiitmine aegub hiljemalt 31. detsembril 2018, on asjakohane jaotada pikendamismenetluse eesmärgil tehtav hindamine liikmesriikide vahel, määrates igale toimeainele referendi ja kaasreferendi.